美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA208213"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
60687-786-21 60687-786 HUMAN PRESCRIPTION DRUG Roflumilast Roflumilast TABLET ORAL 20231101 N/A ANDA ANDA208213 American Health Packaging ROFLUMILAST 500 ug/1 30 BLISTER PACK in 1 CARTON (60687-786-21) / 1 TABLET in 1 BLISTER PACK (60687-786-11)
31722-623-90 31722-623 HUMAN PRESCRIPTION DRUG Roflumilast Roflumilast TABLET ORAL 20221015 N/A ANDA ANDA208213 Camber Pharmaceuticals, Inc. ROFLUMILAST 500 ug/1 90 TABLET in 1 BOTTLE (31722-623-90)
31722-623-32 31722-623 HUMAN PRESCRIPTION DRUG Roflumilast Roflumilast TABLET ORAL 20221015 N/A ANDA ANDA208213 Camber Pharmaceuticals, Inc. ROFLUMILAST 500 ug/1 100 BLISTER PACK in 1 CARTON (31722-623-32) / 10 TABLET in 1 BLISTER PACK (31722-623-31)
31722-623-30 31722-623 HUMAN PRESCRIPTION DRUG Roflumilast Roflumilast TABLET ORAL 20221015 N/A ANDA ANDA208213 Camber Pharmaceuticals, Inc. ROFLUMILAST 500 ug/1 30 TABLET in 1 BOTTLE (31722-623-30)
31722-676-36 31722-676 HUMAN PRESCRIPTION DRUG Roflumilast Roflumilast TABLET ORAL 20230418 N/A ANDA ANDA208213 Camber Pharmaceuticals, Inc. ROFLUMILAST 250 ug/1 1 BLISTER PACK in 1 CARTON (31722-676-36) / 28 TABLET in 1 BLISTER PACK (31722-676-35)
31722-676-32 31722-676 HUMAN PRESCRIPTION DRUG Roflumilast Roflumilast TABLET ORAL 20230418 N/A ANDA ANDA208213 Camber Pharmaceuticals, Inc. ROFLUMILAST 250 ug/1 2 BLISTER PACK in 1 CARTON (31722-676-32) / 10 TABLET in 1 BLISTER PACK (31722-676-31)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase